IND-SWIFT LABORATORIES
Smallcap | BSE
Sector
Here's the live share price of Ind-Swift Laboratories along with daily highs, lows, percentage changes and volume trends, and, all financial information.
3.43₹ 12.95
As on Sep 11, 2026, 04:01 PM IST
Source: Dion Global
Ind-Swift Laboratories Price Performance
Today's LowToday's High
₹374.25₹391.00
₹390.45
52 Weeks' Low52 Weeks' High
₹87.00₹403.00
₹390.45
Open Price
₹374.30
Prev. Close
₹377.50
Volume
43,974
Source: Dion Global
Ind-Swift Laboratories Peer Comparision
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Ind-Swift Laboratories | 10.02 | 37.24 | 146.57 | 172.66 | 262.13 | 61.15 | 41.19 |
| Sun Pharmaceutical Industries | -3.00 | -5.05 | 2.66 | 0.94 | 14.44 | 17.44 | 18.75 |
| Divi's Laboratories | 2.48 | 9.24 | 40.21 | 46.89 | 55.09 | 35.68 | 12.89 |
| Torrent Pharmaceuticals | 2.58 | 2.20 | 8.86 | 12.32 | 38.96 | 38.62 | 26.07 |
| Zydus Lifesciences | -0.13 | -5.13 | 1.25 | 21.42 | 7.28 | 21.21 | 15.05 |
| Cipla | -1.44 | -6.63 | -1.30 | 2.64 | -12.55 | 3.07 | 7.51 |
| Laurus Labs | 7.08 | 5.93 | 41.70 | 89.43 | 120.18 | 69.19 | 24.99 |
| Aurobindo Pharma | 1.34 | 2.04 | 14.44 | 28.43 | 50.99 | 24.52 | 17.88 |
| Dr. Reddy's Laboratories | 0.61 | -3.65 | -8.94 | -12.41 | -10.93 | 1.13 | 3.31 |
| Lupin | -0.71 | -7.99 | -7.83 | -10.64 | 5.40 | 22.94 | 16.33 |
| Mankind Pharma | -2.21 | -6.10 | -3.99 | 1.50 | -12.31 | 8.80 | 9.84 |
| Glenmark Pharmaceuticals | -0.42 | 5.54 | 12.71 | 6.35 | 13.63 | 43.92 | 36.03 |
| Biocon | -1.59 | -9.08 | -6.20 | -1.11 | 7.45 | 12.25 | 2.03 |
| Alkem Laboratories | -1.97 | -7.63 | -4.00 | -8.04 | -5.70 | 11.91 | 5.85 |
| Abbott India | -1.93 | -8.71 | -1.93 | -6.03 | -17.45 | 3.61 | 3.60 |
| Anthem Biosciences | 0.44 | 5.18 | 20.27 | 44.65 | 14.34 | 8.70 | 5.13 |
| Ipca Laboratories | 0.10 | 12.45 | 21.95 | 28.38 | 49.90 | 29.83 | 8.68 |
| Gland Pharma | -0.08 | 0.20 | 27.09 | 75.91 | 49.07 | 20.30 | -5.12 |
| GlaxoSmithKline Pharmaceuticals | -4.34 | 8.98 | 34.59 | 13.88 | -1.18 | 24.68 | 12.96 |
| Ajanta Pharma | 2.10 | 0.96 | 12.64 | 16.15 | 37.46 | 26.89 | 19.98 |
Source: Dion Global
Over the last one year, Ind-Swift Laboratories has gained 262.13% compared to peers like Sun Pharmaceutical Industries (14.44%), Divi's Laboratories (55.09%), Torrent Pharmaceuticals (38.96%). From a 5 year perspective, Ind-Swift Laboratories has outperformed peers relative to Sun Pharmaceutical Industries (18.75%) and Divi's Laboratories (12.89%).
Ind-Swift Laboratories Financials
Source: Dion Global
Ind-Swift Laboratories Stock Technicals
Moving Average
| Day | SMA | EMA |
|---|---|---|
| 5 | 374.02 | 377.27 |
| 10 | 369.18 | 366.84 |
| 20 | 347.85 | 343.93 |
| 50 | 278.94 | 290.47 |
| 100 | 216.27 | 240.4 |
| 200 | 166.96 | 192.64 |
Source: Dion Global
Ind-Swift Laboratories Share Holding Pattern
In the latest quarter, Ind-Swift Laboratories saw a drop in promoter holding to 42.93%, while DII stake increased to 0.17%, FII holding fell to 10.70%, and public shareholding moved up to 46.19% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Ind-Swift Laboratories Corporate Actions
Date Time | Announcement |
|---|---|
| Sep 06, 2026, 02:19 AM IST IST | Ind-Swift Lab. - Reg. 34 (1) Annual Report. |
| Sep 06, 2026, 01:14 AM IST IST | Ind-Swift Lab. - Notice Of 31St Annual General Meeting Scheduled To Be Held On Sept. 30, 2026 |
| Sep 04, 2026, 08:32 PM IST IST | Ind-Swift Lab. - Outcome Of Preferential Issue Committee Meeting Held On Friday, 4Th September, 2026, As Per Regulation 30 Of |
| Sep 03, 2026, 12:14 AM IST IST | Ind-Swift Lab. - Board Meeting Outcome for Outcome Of Board Meeting Held On September 02, 2026 |
| Aug 27, 2026, 08:37 PM IST IST | Ind-Swift Lab. - Clarification On Movement In Volume |
Source: Dion Global
About Ind-Swift Laboratories
Ind-Swift Laboratories Ltd. is a Public Limited Listed company incorporated on 04/01/1995 and has its registered office in the State of Chandigarh, India. Company's Corporate Identification Number(CIN) is L24232CH1995PLC015553 and registration number is 015553. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company's Total Operating Revenue is Rs. 635.89 Cr. and Equity Capital is Rs. 86.84 Cr. for the Year ended 31/03/2026.
- IndustryPharmaceuticals
- AddressSCO 850, Shivalik Enclave, Chandigarh Chandigarh 160101
- Contact
Source: Dion Global
Management
- Mr. Navrattan MunjalChairman & Managing Director
- Mr. Himanshu JainJoint Managing Director
- Mr. Rishav MehtaExecutive Director
- Mr. Sahil MunjalExecutive Director
- Mr. Rajinder Kumar GuptaIndependent Director
- Mr. Prabhat KhuranaIndependent Director
- Mr. Subodh GuptaIndependent Director
- Ms. Neerja ChathleyIndependent Woman Director
FAQs on Ind-Swift Laboratories Share Price
What is the share price of Ind-Swift Laboratories?
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Ind-Swift Laboratories is ₹390.45 as on Sep 11, 2026.
What kind of stock is Ind-Swift Laboratories?
The Ind-Swift Laboratories is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
What is the Market Cap of Ind-Swift Laboratories?
The market cap of Ind-Swift Laboratories is ₹3,395.41 Cr as on Sep 11, 2026.
What are today's High and Low prices of Ind-Swift Laboratories?
Today’s highest and lowest price of Ind-Swift Laboratories are ₹391.00 and ₹374.25.
What are the 52 Week High and 52 Week Low of Ind-Swift Laboratories?
The 52-week high/low is the highest and lowest price at which Ind-Swift Laboratories stock has traded in the past 52-week or nearly a year. The 52-week high of Ind-Swift Laboratories is ₹403.00 and 52-week low of Ind-Swift Laboratories is ₹87.00 as on Sep 11, 2026.
How has the Ind-Swift Laboratories performed historically in terms of returns?
The Ind-Swift Laboratories has shown returns of 3.43% over the past day, 37.24% for the past month, 146.57% over 3 months, 262.13% over 1 year, 61.15% across 3 years, and 41.19% over 5 years.
What are the P/E ratio, dividend yield and PB ratio of Ind-Swift Laboratories?
P/E ratio of and PB ratio of Ind-Swift Laboratories are 59.24 and 2.41 on Sep 11, 2026. While the company gives a dividend yield of 0.00 per annum.
Source: Dion Global
✕